Sleep restriction may contribute to poor health, including an increased risk for insulin resistance, type 2 diabetes, and obesity. In addition, fewer hours of sleep can adversely affect molecular metabolic pathways in peripheral human adipocytes, according to a clinical study published in the October issue of Annals of Internal Medicine.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.